Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Nano-drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Selecta Biosciences
GlaxoSmithKline
Abbott
Kaken Pharmaceutical
Cerulean Pharma
Roche
Gilead Sciences
Merck
Stryker
Sanofi
Celgene
Novartis
OSI Pharmaceuticals
Eli Lilly
Johnson & Johnson
Astrazeneca
Pfizer
Mitsubishi Pharma
Navidea Biopharmaceuticals
Novavax
Kadmon Pharmaceuticals
By Type:
Polymeric Micelles
Liposomes
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension
By Application:
Cancer and Tumors
Autoimmune Disorders
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Nano-drug Market Overview 2018-2029
-
1.1 China Nano-drug Industry Development Overview
-
1.2 China Nano-drug Industry Development History
-
1.3 China Nano-drug Industry Market Size (2018-2029)
-
1.4 China Nano-drug Market Analysis by Type from Production Side
-
1.4.1 China Nano-drug Production Volume, Production Value and Growth Rate of Polymeric Micelles (2018-2029)
-
1.4.2 China Nano-drug Production Volume, Production Value and Growth Rate of Liposomes (2018-2029)
-
1.4.3 China Nano-drug Production Volume, Production Value and Growth Rate of Solid lipid Nanoparticles (2018-2029)
-
1.4.4 China Nano-drug Production Volume, Production Value and Growth Rate of Microemulsion and Nanoemulsion (2018-2029)
-
1.4.5 China Nano-drug Production Volume, Production Value and Growth Rate of Nanosuspension (2018-2029)
-
1.5 China Nano-drug Market Analysis by Application from Consumption End
-
1.5.1 China Nano-drug Sales Volume, Sales Value and Growth Rate of Cancer and Tumors (2018-2029)
-
1.5.2 China Nano-drug Sales Volume, Sales Value and Growth Rate of Autoimmune Disorders (2018-2029)
-
1.6 China Nano-drug Market Analysis by Region
-
1.6.1 North China Nano-drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Nano-drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Nano-drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Nano-drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Nano-drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Nano-drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Nano-drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Nano-drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Nano-drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Nano-drug Market Status and Competition Analysis in 2023
-
2.2.3 China Nano-drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Nano-drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Nano-drug Industry Development
Chapter 3 Nano-drugIndustry Chain Analysis
-
3.1 Nano-drug Industry Chain
-
3.2 Nano-drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Nano-drug Market
-
3.3 Nano-drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Nano-drug Market
Chapter 4 China Nano-drug Market, by Type
-
4.1 China Nano-drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Nano-drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Nano-drug Production Volume and Growth Rate, by Type
-
4.5.1 China Nano-drug Production Volume and Growth Rate of Polymeric Micelles
-
4.5.2 China Nano-drug Production Volume and Growth Rate of Liposomes
-
4.5.3 China Nano-drug Production Volume and Growth Rate of Solid lipid Nanoparticles
-
4.5.4 China Nano-drug Production Volume and Growth Rate of Microemulsion and Nanoemulsion
-
4.5.5 China Nano-drug Production Volume and Growth Rate of Nanosuspension
Chapter 5 China Nano-drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Nano-drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Nano-drug Market Size and Growth Rate, by Application
-
5.5.1 China Nano-drug Market Size and Growth Rate of Cancer and Tumors
-
5.5.2 China Nano-drug Market Size and Growth Rate of Autoimmune Disorders
Chapter 6 China Nano-drug Market, by Region
-
6.1 China Nano-drug Production Volume and Production Value, by Region
-
6.2 China Nano-drug Sales Volume and Sales Value, by Region
Chapter 7 North China Nano-drug Market Analysis
-
7.1 North China Nano-drug Market, by Type
-
7.2 North China Nano-drug Market, by Application
Chapter 8 Central China Nano-drug Market Analysis
-
8.1 Central China Nano-drug Market, by Type
-
8.2 Central China Nano-drug Market, by Application
Chapter 9 South China Nano-drug Market Analysis
-
9.1 South China Nano-drug Market, by Type
-
9.2 South China Nano-drug Market, by Application
Chapter 10 East China Nano-drug Market Analysis
-
10.1 East China Nano-drug Market, by Type
-
10.2 East China Nano-drug Market, by Application
Chapter 11 Northeast China Nano-drug Market Analysis
-
11.1 Northeast China Nano-drug Market, by Type
-
11.2 Northeast China Nano-drug Market, by Application
Chapter 12 Southwest China Nano-drug Market Analysis
-
12.1 Southwest China Nano-drug Market, by Type
-
12.2 Southwest China Nano-drug Market, by Application
Chapter 13 Northwest China Nano-drug Market Analysis
-
13.1 Northwest China Nano-drug Market, by Type
-
13.2 Northwest China Nano-drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Selecta Biosciences
-
14.1.1 Selecta Biosciences Company Profile
-
14.1.2 Selecta Biosciences Nano-drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Profile
-
14.2.2 GlaxoSmithKline Nano-drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Abbott
-
14.3.1 Abbott Company Profile
-
14.3.2 Abbott Nano-drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Kaken Pharmaceutical
-
14.4.1 Kaken Pharmaceutical Company Profile
-
14.4.2 Kaken Pharmaceutical Nano-drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Cerulean Pharma
-
14.5.1 Cerulean Pharma Company Profile
-
14.5.2 Cerulean Pharma Nano-drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Roche
-
14.6.1 Roche Company Profile
-
14.6.2 Roche Nano-drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Gilead Sciences
-
14.7.1 Gilead Sciences Company Profile
-
14.7.2 Gilead Sciences Nano-drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Merck
-
14.8.1 Merck Company Profile
-
14.8.2 Merck Nano-drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Stryker
-
14.9.1 Stryker Company Profile
-
14.9.2 Stryker Nano-drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Sanofi
-
14.10.1 Sanofi Company Profile
-
14.10.2 Sanofi Nano-drug Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Celgene
-
14.11.1 Celgene Company Profile
-
14.11.2 Celgene Nano-drug Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Novartis
-
14.12.1 Novartis Company Profile
-
14.12.2 Novartis Nano-drug Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 OSI Pharmaceuticals
-
14.13.1 OSI Pharmaceuticals Company Profile
-
14.13.2 OSI Pharmaceuticals Nano-drug Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Eli Lilly
-
14.14.1 Eli Lilly Company Profile
-
14.14.2 Eli Lilly Nano-drug Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Johnson & Johnson
-
14.15.1 Johnson & Johnson Company Profile
-
14.15.2 Johnson & Johnson Nano-drug Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Astrazeneca
-
14.16.1 Astrazeneca Company Profile
-
14.16.2 Astrazeneca Nano-drug Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Pfizer
-
14.17.1 Pfizer Company Profile
-
14.17.2 Pfizer Nano-drug Market Performance
-
14.17.3 Product&Service Introduction
-
14.18 Mitsubishi Pharma
-
14.18.1 Mitsubishi Pharma Company Profile
-
14.18.2 Mitsubishi Pharma Nano-drug Market Performance
-
14.18.3 Product&Service Introduction
-
14.19 Navidea Biopharmaceuticals
-
14.19.1 Navidea Biopharmaceuticals Company Profile
-
14.19.2 Navidea Biopharmaceuticals Nano-drug Market Performance
-
14.19.3 Product&Service Introduction
-
14.20 Novavax
-
14.20.1 Novavax Company Profile
-
14.20.2 Novavax Nano-drug Market Performance
-
14.20.3 Product&Service Introduction
-
14.21 Kadmon Pharmaceuticals
-
14.21.1 Kadmon Pharmaceuticals Company Profile
-
14.21.2 Kadmon Pharmaceuticals Nano-drug Market Performance
-
14.21.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Nano-drug Industry Research Conclusions
-
15.2 Nano-drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Nano-drug Industry Market Size (2018-2029)
-
Figure China Nano-drug Production Volume, Production Value and Growth Rate of Polymeric Micelles (2018-2029)
-
Figure China Nano-drug Production Volume, Production Value and Growth Rate of Liposomes (2018-2029)
-
Figure China Nano-drug Production Volume, Production Value and Growth Rate of Solid lipid Nanoparticles (2018-2029)
-
Figure China Nano-drug Production Volume, Production Value and Growth Rate of Microemulsion and Nanoemulsion (2018-2029)
-
Figure China Nano-drug Production Volume, Production Value and Growth Rate of Nanosuspension (2018-2029)
-
Figure China Nano-drug Sales Volume, Sales Value and Growth Rate of Cancer and Tumors (2018-2029)
-
Figure China Nano-drug Sales Volume, Sales Value and Growth Rate of Autoimmune Disorders (2018-2029)
-
Figure North China Nano-drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Nano-drug Market Size and Growth Rate from 2018-2029
-
Figure South China Nano-drug Market Size and Growth Rate from 2018-2029
-
Figure East China Nano-drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Nano-drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Nano-drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Nano-drug Market Size and Growth Rate from 2018-2029
-
Figure Nano-drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Nano-drug Market Share by Type in 2018
-
Figure China Nano-drug Market Share by Type in 2023
-
Figure China Nano-drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Nano-drug Production Volume and Growth Rate of Polymeric Micelles (2018-2023)
-
Figure China Nano-drug Production Volume and Growth Rate of Liposomes (2018-2023)
-
Figure China Nano-drug Production Volume and Growth Rate of Solid lipid Nanoparticles (2018-2023)
-
Figure China Nano-drug Production Volume and Growth Rate of Microemulsion and Nanoemulsion (2018-2023)
-
Figure China Nano-drug Production Volume and Growth Rate of Nanosuspension (2018-2023)
-
Figure China Nano-drug Market Share by Application in 2018
-
Figure China Nano-drug Market Share by Application in 2023
-
Figure China Nano-drug Total Market Size and Growth Rate from Consumption End
-
Figure China Nano-drug Market Size and Growth Rate of Cancer and Tumors (2018-2023)
-
Figure China Nano-drug Market Size and Growth Rate of Autoimmune Disorders (2018-2023)
-
Table China Nano-drug Production Volume by Region (2018-2023)
-
Table China Nano-drug Production Volume Share by Region (2018-2023)
-
Figure China Nano-drug Production Volume Share by Region (2018-2023)
-
Table China Nano-drug Production Value by Region (2018-2023)
-
Table China Nano-drug Production Value Share by Region (2018-2023)
-
Figure China Nano-drug Production Value Share by Region (2018-2023)
-
Table China Nano-drug Sales Volume by Region (2018-2023)
-
Table China Nano-drug Sales Volume Share by Region (2018-2023)
-
Figure China Nano-drug Sales Volume Share by Region (2018-2023)
-
Table China Nano-drug Sales Value by Region (2018-2023)
-
Table China Nano-drug Sales Value Share by Region (2018-2023)
-
Figure China Nano-drug Sales Value Share by Region (2018-2023)
-
Table North China Nano-drug Production Volume by Type (2018-2023)
-
Table North China Nano-drug Production Volume Share by Type (2018-2023)
-
Figure North China Nano-drug Production Volume Share by Type (2018-2023)
-
Table North China Nano-drug Sales Volume by Application (2018-2023)
-
Table North China Nano-drug Sales Volume Share by Application (2018-2023)
-
Figure North China Nano-drug Sales Volume Share by Application (2018-2023)
-
Table Central China Nano-drug Production Volume by Type (2018-2023)
-
Table Central China Nano-drug Production Volume Share by Type (2018-2023)
-
Figure Central China Nano-drug Production Volume Share by Type (2018-2023)
-
Table Central China Nano-drug Sales Volume by Application (2018-2023)
-
Table Central China Nano-drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Nano-drug Sales Volume Share by Application (2018-2023)
-
Table South China Nano-drug Production Volume by Type (2018-2023)
-
Table South China Nano-drug Production Volume Share by Type (2018-2023)
-
Figure South China Nano-drug Production Volume Share by Type (2018-2023)
-
Table South China Nano-drug Sales Volume by Application (2018-2023)
-
Table South China Nano-drug Sales Volume Share by Application (2018-2023)
-
Figure South China Nano-drug Sales Volume Share by Application (2018-2023)
-
Table East China Nano-drug Production Volume by Type (2018-2023)
-
Table East China Nano-drug Production Volume Share by Type (2018-2023)
-
Figure East China Nano-drug Production Volume Share by Type (2018-2023)
-
Table East China Nano-drug Sales Volume by Application (2018-2023)
-
Table East China Nano-drug Sales Volume Share by Application (2018-2023)
-
Figure East China Nano-drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Nano-drug Production Volume by Type (2018-2023)
-
Table Northeast China Nano-drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Nano-drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Nano-drug Sales Volume by Application (2018-2023)
-
Table Northeast China Nano-drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Nano-drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Nano-drug Production Volume by Type (2018-2023)
-
Table Southwest China Nano-drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Nano-drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Nano-drug Sales Volume by Application (2018-2023)
-
Table Southwest China Nano-drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Nano-drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Nano-drug Production Volume by Type (2018-2023)
-
Table Northwest China Nano-drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Nano-drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Nano-drug Sales Volume by Application (2018-2023)
-
Table Northwest China Nano-drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Nano-drug Sales Volume Share by Application (2018-2023)
-
Table Selecta Biosciences Company Profile
-
Table Selecta Biosciences Nano-drug Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Abbott Company Profile
-
Table Abbott Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Kaken Pharmaceutical Company Profile
-
Table Kaken Pharmaceutical Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Cerulean Pharma Company Profile
-
Table Cerulean Pharma Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Gilead Sciences Company Profile
-
Table Gilead Sciences Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Stryker Company Profile
-
Table Stryker Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Celgene Company Profile
-
Table Celgene Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Nano-drug Revenue, Price and Gross (2018-2023)
-
Table OSI Pharmaceuticals Company Profile
-
Table OSI Pharmaceuticals Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Johnson & Johnson Company Profile
-
Table Johnson & Johnson Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Astrazeneca Company Profile
-
Table Astrazeneca Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Mitsubishi Pharma Company Profile
-
Table Mitsubishi Pharma Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Navidea Biopharmaceuticals Company Profile
-
Table Navidea Biopharmaceuticals Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Novavax Company Profile
-
Table Novavax Nano-drug Revenue, Price and Gross (2018-2023)
-
Table Kadmon Pharmaceuticals Company Profile
-
Table Kadmon Pharmaceuticals Nano-drug Revenue, Price and Gross (2018-2023)
-
